BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 7632812)

  • 1. Thrombotic thrombocytopenic purpura/hemolytic uremic syndrome: a multivariate analysis of factors predicting the response to plasma exchange.
    Pereira A; Mazzara R; Monteagudo J; Sanz C; Puig L; Martínez A; Ordinas A; Castillo R
    Ann Hematol; 1995 Jun; 70(6):319-23. PubMed ID: 7632812
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Thrombotic thrombocytopenic purpura-hemolytic uremic syndrome (TTP-HUS): a 24-year clinical experience with 178 patients.
    Levandovsky M; Harvey D; Lara P; Wun T
    J Hematol Oncol; 2008 Dec; 1():23. PubMed ID: 19046460
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Clinical analysis on thrombotic thrombocytopenic purpura and hemolytic uremic syndrome, with plasma level of cytokine].
    Wada H; Saitoh M; Tamaki S; Masuya M; Morita K; Tabata M; Tanigawa M; Kageyama S; Tsuzi K; Ohta C
    Rinsho Ketsueki; 1990 Sep; 31(9):1537-43. PubMed ID: 2246829
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High-dose plasma infusion versus plasma exchange as early treatment of thrombotic thrombocytopenic purpura/hemolytic-uremic syndrome.
    Coppo P; Bussel A; Charrier S; Adrie C; Galicier L; Boulanger E; Veyradier A; Leblanc T; Alberti C; Azoulay E; Le Gall JR; Schlemmer B
    Medicine (Baltimore); 2003 Jan; 82(1):27-38. PubMed ID: 12544708
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pathophysiology and treatment of thrombotic thrombocytopenic purpura/hemolytic uremic syndrome (TTP/HUS).
    Kakishita E
    Int J Hematol; 2000 Jun; 71(4):320-7. PubMed ID: 10905050
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Microangiopathic hemolytic anemias. Clinical pattern, therapy and clinical course in 14 patients with thrombotic thrombocytopenic purpura and hemolytic uremic syndrome].
    Krause M; Fehr J; Gmür J; Keusch G; Frick P; Oelz O
    Schweiz Med Wochenschr; 1986 Nov; 116(48):1666-74. PubMed ID: 3798063
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Thrombotic thrombocytopenic purpura/hemolytic uremic syndrome (TTP/HUS): treatment outcome, relapses, prognostic factors. A single-center experience of 48 cases.
    Dervenoulas J; Tsirigotis P; Bollas G; Pappa V; Xiros N; Economopoulos T; Pappa M; Mellou S; Kostourou A; Papageorgiou E; Raptis SA
    Ann Hematol; 2000 Feb; 79(2):66-72. PubMed ID: 10741917
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Thrombotic thrombocytopenic purpura-hemolytic uremic syndrome: pathophysiology and management.
    Myers L
    Nephrol Nurs J; 2002 Apr; 29(2):171-80; quiz 181-2. PubMed ID: 11997952
    [TBL] [Abstract][Full Text] [Related]  

  • 9. How I treat patients with thrombotic thrombocytopenic purpura-hemolytic uremic syndrome.
    George JN
    Blood; 2000 Aug; 96(4):1223-9. PubMed ID: 10942361
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pathophysiology and management of thrombotic microangiopathies.
    Ruggenenti P; Remuzzi G
    J Nephrol; 1998; 11(6):300-10. PubMed ID: 10048496
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interventions for hemolytic uremic syndrome and thrombotic thrombocytopenic purpura: a systematic review of randomized controlled trials.
    Michael M; Elliott EJ; Craig JC; Ridley G; Hodson EM
    Am J Kidney Dis; 2009 Feb; 53(2):259-72. PubMed ID: 18950913
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thrombotic thrombocytopenic purpura and hemolytic uremic syndrome.
    Elliott MA; Nichols WL
    Mayo Clin Proc; 2001 Nov; 76(11):1154-62. PubMed ID: 11702904
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Re-examination of 30-day survival and relapse rates in patients with thrombotic thrombocytopenic purpura-hemolytic uremic syndrome.
    Bittencourt CE; Ha JP; Maitta RW
    PLoS One; 2015; 10(5):e0127744. PubMed ID: 26000799
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Thrombotic thrombocytopenic purpura/haemolytic uraemic syndrome: a new index predicting response to plasma exchange.
    Wyllie BF; Garg AX; Macnab J; Rock GA; Clark WF;
    Br J Haematol; 2006 Jan; 132(2):204-9. PubMed ID: 16398654
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thrombotic thrombocytopenic purpura-hemolytic uremic syndrome: diagnosis and management.
    George JN; Gilcher RO; Smith JW; Chandler L; Duvall D; Ellis C
    J Clin Apher; 1998; 13(3):120-5. PubMed ID: 9828022
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Extracorporeal plasma treatment in thrombotic thrombocytopenic purpura and hemolytic uremic syndrome: a review.
    Bosch T; Wendler T
    Ther Apher; 2001 Jun; 5(3):182-5. PubMed ID: 11467754
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The renal manifestations and outcome of thrombotic thrombocytopenic purpura/hemolytic uremic syndrome in adults.
    Conlon PJ; Howell DN; Macik G; Kovalik EC; Smith SR
    Nephrol Dial Transplant; 1995; 10(7):1189-93. PubMed ID: 7478122
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Improved survival with plasma exchange in patients with thrombotic thrombocytopenic purpura-hemolytic uremic syndrome.
    Lara PN; Coe TL; Zhou H; Fernando L; Holland PV; Wun T
    Am J Med; 1999 Dec; 107(6):573-9. PubMed ID: 10625026
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Therapeutic plasma exchange in patients with thrombotic thrombocytopenic purpura-hemolytic uremic syndrome: the 10-year experience of a single center.
    Kim JW; Kim I; Oh KH; Yoon SS; Oh MD; Song YW; Heo DS; Bang YJ; Han KS; Han JS; Park S; Kim BK
    Hematology; 2011 Mar; 16(2):73-9. PubMed ID: 21418736
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Therapeutic plasma exchange does not appear to be effective in the management of thrombotic thrombocytopenic purpura/hemolytic uremic syndrome following bone marrow transplantation.
    Sarode R; McFarland JG; Flomenberg N; Casper JT; Cohen EP; Drobyski WR; Ash RC; Horowitz MM; Camitta B; Lawton C
    Bone Marrow Transplant; 1995 Aug; 16(2):271-5. PubMed ID: 7581147
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.